<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A96FDC1-7FB1-4FD1-BB28-59886157E3BD"><gtr:id>5A96FDC1-7FB1-4FD1-BB28-59886157E3BD</gtr:id><gtr:name>Memorial Sloane Kettering Cancer Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C3ED34B5-76A5-42E4-B75E-2BE513E68328"><gtr:id>C3ED34B5-76A5-42E4-B75E-2BE513E68328</gtr:id><gtr:name>University of Navarra</gtr:name><gtr:address><gtr:line1>Campus Universitario</gtr:line1><gtr:line4>E-31080 Pamplona</gtr:line4><gtr:line5>Navarra</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F732250B-1EB7-4E99-8CDE-04DEB18630B5"><gtr:id>F732250B-1EB7-4E99-8CDE-04DEB18630B5</gtr:id><gtr:name>Victor Segalen Bordeaux 2 University</gtr:name><gtr:address><gtr:line1>Universite Victor Segalen Bordeaux 2</gtr:line1><gtr:line2>146 rue Leo Saignat</gtr:line2><gtr:line4>Bordeaux</gtr:line4><gtr:line5>Cedex</gtr:line5><gtr:postCode>33076</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9ACD02BB-EC4C-4346-A6A0-801468590A83"><gtr:id>9ACD02BB-EC4C-4346-A6A0-801468590A83</gtr:id><gtr:name>Tufts University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4FD0CEEE-FD4E-40D6-AA08-ADFB5D4476E1"><gtr:id>4FD0CEEE-FD4E-40D6-AA08-ADFB5D4476E1</gtr:id><gtr:name>United Arab Emirates University</gtr:name><gtr:address><gtr:line1>UAE University</gtr:line1><gtr:postCode>17666</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A96FDC1-7FB1-4FD1-BB28-59886157E3BD"><gtr:id>5A96FDC1-7FB1-4FD1-BB28-59886157E3BD</gtr:id><gtr:name>Memorial Sloane Kettering Cancer Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C3ED34B5-76A5-42E4-B75E-2BE513E68328"><gtr:id>C3ED34B5-76A5-42E4-B75E-2BE513E68328</gtr:id><gtr:name>University of Navarra</gtr:name><gtr:address><gtr:line1>Campus Universitario</gtr:line1><gtr:line4>E-31080 Pamplona</gtr:line4><gtr:line5>Navarra</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F732250B-1EB7-4E99-8CDE-04DEB18630B5"><gtr:id>F732250B-1EB7-4E99-8CDE-04DEB18630B5</gtr:id><gtr:name>Victor Segalen Bordeaux 2 University</gtr:name><gtr:address><gtr:line1>Universite Victor Segalen Bordeaux 2</gtr:line1><gtr:line2>146 rue Leo Saignat</gtr:line2><gtr:line4>Bordeaux</gtr:line4><gtr:line5>Cedex</gtr:line5><gtr:postCode>33076</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9ACD02BB-EC4C-4346-A6A0-801468590A83"><gtr:id>9ACD02BB-EC4C-4346-A6A0-801468590A83</gtr:id><gtr:name>Tufts University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4FD0CEEE-FD4E-40D6-AA08-ADFB5D4476E1"><gtr:id>4FD0CEEE-FD4E-40D6-AA08-ADFB5D4476E1</gtr:id><gtr:name>United Arab Emirates University</gtr:name><gtr:address><gtr:line1>UAE University</gtr:line1><gtr:postCode>17666</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/AA85AE6A-D3AA-426F-A3E8-06C8403421A4"><gtr:id>AA85AE6A-D3AA-426F-A3E8-06C8403421A4</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Farndale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/067002FC-868F-4295-ADF6-AA7494C3EA47"><gtr:id>067002FC-868F-4295-ADF6-AA7494C3EA47</gtr:id><gtr:firstName>Birgit</gtr:firstName><gtr:surname>Leitinger</gtr:surname><gtr:orcidId>0000-0003-2426-1179</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701121"><gtr:id>E5D02058-436A-481D-9B2F-00D93A036CAF</gtr:id><gtr:title>The discoidin domain receptors: collagen binding specificity and cooperation with integrins in cell adhesion / migration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701121</gtr:grantReference><gtr:abstractText>We aim to study how cells use specialised proteins, called DDRs, to interact with collagen. When DDRs are faulty, they can cause disease. It is hoped that our work will benefit human health by creating reagents that may be useful in anti-DDR drug discovery programmes.

The DDRs are novel drug targets for a number of human diseases, including arthritis and certain cancers. The DDRs recognise collagen, but we know very little about this interaction. When the DDRs bind collagen, they transmit a signal into the cell. We do not understand how the DDRs transmit such information. 

Collagen is the most abundant protein in our body and has a very complex structure. It is built like a rope, composed of three very long strands of amino acids that wind around each other. We will characterise the parts of collagen that are recognised by the DDRs. We will produce synthetic collagen fragments with the same rope-like structure as collagen and test which of these the DDRs use to transmit signals into cells. 

The DDRs are not the only proteins that interact with collagen. Another type of protein called integrin also binds collagen. Because the DDRs and integrins both recognise collagen, their relative contribution to biological function has been difficult to study. We have recently discovered that DDRs recognise a different part of collagen than integrins. We can thus make synthetic collagen fragments that will bind only DDRs, but not integrins, and use these to understand how the DDRs regulate the cell?s function.</gtr:abstractText><gtr:technicalSummary>The human discoidin domain receptors, DDR1 and DDR2, are highly unusual receptor tyrosine kinases that are activated by a major constituent of the extracellular matrix, collagen. Next to the collagen-binding integrins, the DDRs are the most widely distributed collagen receptors in mammals. The DDRs are important in development and aberrant DDR function leads to human disease. In particular, DDRs are responsible for disease progression in fibrotic diseases, arthritis and several types of cancer. In contrast to the situation with integrins, not much is known about the DDR-collagen interaction. Both DDRs are activated by a number of different collagen types, and activation is strictly dependent on the native, triple-helical conformation of collagen.

Our previous work has shown that the DDRs bind collagen with high affinity and in a highly specific manner. Very recently, using synthetic triple-helical peptides derived from collagen, we identified a specific sequence in collagen II recognised by DDR2 (unpublished results). This amino acid motif is distinct from that recognised by integrins and the platelet collagen receptor GPVI. Importantly, triple-helical peptides comprising the DDR2 binding site not only inhibit DDR2 binding to collagen II, but activate DDR2 autophosphorylation in a specific manner. Thus, we are now in a unique position to use high-affinity DDR2-specific collagen peptides as a research tool to investigate the cellular function of DDR2.

The aims of this proposal are twofold: 1) to define DDR1 and DDR2 binding sites in other collagens, and 2) to use our DDR-selective ligands to probe the contribution of the DDRs to cell adhesion and migration. Although the two DDRs are homologous, their collagen binding specificities are distinct; our studies will establish the molecular basis for these differences. The DDRs play important roles in cell adhesion and migration, but integrins are thought to be the primary mediators of these processes. The fact that both types of receptor recognise the same ligand (collagen) has complicated the analysis of their relative contributions. Using our new DDR-specific peptides, together with previously developed integrin-specific peptides, we are now able to discriminate between integrin-initiated and DDR-initiated events in cell adhesion and migration. We will study the possible cooperation between the DDRs and integrins. The results obtained from this research programme will establish the collagen binding specificities of the DDRs and give important novel insight into the roles of the DDRs in cell adhesion and migration.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-19</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-08-20</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>323374</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Cancer Research UK (ICR)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Cancer Biology</gtr:department><gtr:description>Proteomics of DDR2</gtr:description><gtr:id>6ECC1018-279F-4146-84D3-E91AC491087C</gtr:id><gtr:impact>Manuscript published: Iwai et al, Biochem J, 2013.</gtr:impact><gtr:partnerContribution>performed research on DDR2 phosphoproteomics</gtr:partnerContribution><gtr:piContribution>provided reagents, did flow cytometry assays, provided guidance on research and manuscript writing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Navarra</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Center for Applied Medical Research</gtr:department><gtr:description>Role of DDR1 in lung cancer</gtr:description><gtr:id>2BF5BB60-AF8F-4EF1-B1F7-B5B08EF28465</gtr:id><gtr:impact>Publication in Clin Cancer Research, doi: 10.1158/1078-0432.CCR-11-1686; invitation to give seminar in Pamplona; invitation to be external examiner for thesis in Spain and invitation to give research seminar in Spain</gtr:impact><gtr:partnerContribution>For new experiments, the partner will provide us with cell lines</gtr:partnerContribution><gtr:piContribution>Provided training in receptor activation assays, provided antibody that was made in my lab, will analyse the function of DDR1 in lung cancer cell lines</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>University College London (UCL), UCL Cancer Institute</gtr:department><gtr:description>Role of DDR1 in cell migration</gtr:description><gtr:id>4119AE78-235E-46FF-ABB3-11FBE5CC4129</gtr:id><gtr:impact>A manuscript describing the findings has been published (Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S.I., Williamson, P., Harrington, K., Leitinger, B., &amp;amp; Sahai, E. (2011). Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat. Cell Biol., 13, 49-58.)</gtr:impact><gtr:partnerContribution>The collaborators have identified a novel role for DDR1, the protein of interest in the MRC-funded grant, in cell migration.</gtr:partnerContribution><gtr:piContribution>Provide essential reagents for the study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Memorial Sloane Kettering Cancer Centre</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Weill Graduate School of Biomedical Sciences</gtr:department><gtr:description>Role of DDR1 in cancer dormancy</gtr:description><gtr:id>EFE87F94-A220-4399-83F0-9A2A5816F24A</gtr:id><gtr:impact>Publlcation, Gao et al, Cell, 2016. doi: 10.1016/j.cell.2016.06.009</gtr:impact><gtr:partnerContribution>research on role of DDR1 in cancer dormancy</gtr:partnerContribution><gtr:piContribution>Provide antibodies made in my lab that are not commercially available; provide hybridoma cells to allow Ab production</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bordeaux Segalen</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INSERN (1053) (Universit? Bordeaux Segalen)</gtr:department><gtr:description>Role of DDR1 in invadosomes</gtr:description><gtr:id>7A202C4F-1B2C-4CAE-B1EC-2F65ADF49167</gtr:id><gtr:impact>Invitation to give seminar in Bordeaux, manuscript published (Juin et al, J Cell Biol, 2014); doi: 10.1083/jcb.201404079</gtr:impact><gtr:partnerContribution>Research on role of DDR1 in invadosome formation</gtr:partnerContribution><gtr:piContribution>Advice on how to do receptor activation assays; provided antibodies made in my lab</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tufts University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biomedical Engineering</gtr:department><gtr:description>Study with engineered bacterial collagen</gtr:description><gtr:id>A5390377-6029-4854-A1F3-D198F74401EE</gtr:id><gtr:impact>Published paper (An et al, JBC, 2015)</gtr:impact><gtr:partnerContribution>Provided engineered recombinant collagen for experiments</gtr:partnerContribution><gtr:piContribution>MRC and BBSRC employed post doc and PhD student performed experiments with material obtained from collaborators at Tufts university</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>United Arab Emirates University</gtr:collaboratingOrganisation><gtr:country>United Arab Emirates</gtr:country><gtr:description>Characterisation of DDR2 SMED mutants</gtr:description><gtr:id>9F5F177F-2754-4D7E-8DB7-C6D20D024C51</gtr:id><gtr:impact>A manuscript reporting the collaborative findings has been published in 2010 (see Publications, Ali et al, 2010)</gtr:impact><gtr:partnerContribution>The collaborators have identified disease-causing mutants of DDR2, the protein we study in MRC-funded research. Together with the collaborators we have identified the underlying causes for a growth defect caused by DDR2 missense mutations. A manuscript reporting these findings has been published in 2010.</gtr:partnerContribution><gtr:piContribution>We performed experiments that characterised biochemically the DDR2 missense mutations identified by our collaborators</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>439000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant; Discoidin domain receptor signalling: from crystal structures to mechanisms</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>BFF760A2-8A33-4C96-9C1B-54A6EC200680</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>DDR1 is a novel drug target for a number of human diseases. Function-blocking antibodies against DDR1, which were made prior to the MRC-funded research were characterised with MRC funds. These antibodies have the potential to be developed into therapeutic antibodies that could be used in a number of human diseases where DDR1 is involved in disease progression.</gtr:description><gtr:id>AC591F5D-72EB-4542-9876-FD18996CBF67</gtr:id><gtr:impact>no impacts yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>GB1115529.8; WO/2013/034933</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Blocking antibodies against DDR1</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Anti-DDR1 mAb 5D5, which was characterised with MRC funds, was licensed to Millipore for sale</gtr:description><gtr:id>4853E3D2-6156-4653-A4E3-E00BD7FDECA7</gtr:id><gtr:impact>no other impacts so far</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:protection>Protection not required</gtr:protection><gtr:title>Anti-DDR1 mAb licensed</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Although the anti-DDR1 antibodies were created without MRC funds, MRC funds helped to characterise these antibodies.</gtr:description><gtr:id>7104970D-A0DE-4ED7-93A3-A3519E177B9C</gtr:id><gtr:impact>The antibodies used by my collaborators led to two high impact publications: 
Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S.I., Williamson, P., Harrington, K., Leitinger, B., &amp;amp; Sahai, E. (2011). Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat. Cell Biol., 13, 49-58.

Juin A, Di Martino, J, Leitinger, B, Henriet, E, Gary, AS, Paysan, L, Bomo, J, Baffet, G, Gauthier Rouviere C, Rosenbaum, J, Moreau, V &amp;amp; Saltel, F (2014). Discoidin domain receptor 1 controls linear invadosome formation via Cdc42/Tuba pathway, J Cell Biol, in press

The antibodies were described in Carafoli et al, Structure (2012) and have led to new collaborations.

The antibodies are also the basis for a patent.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>anti-DDR1 antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7092C3D5-99DF-47EA-83A0-4497D682D156"><gtr:id>7092C3D5-99DF-47EA-83A0-4497D682D156</gtr:id><gtr:title>Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.</gtr:title><gtr:parentPublicationTitle>Matrix biology : journal of the International Society for Matrix Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/826a25c7465d2afb1646f4e48ce371b8"><gtr:id>826a25c7465d2afb1646f4e48ce371b8</gtr:id><gtr:otherNames>Borza CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0945-053X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0CA41C98-6EDC-457F-A1F8-D2D248D88DA0"><gtr:id>0CA41C98-6EDC-457F-A1F8-D2D248D88DA0</gtr:id><gtr:title>Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4cc85d0fa6cc2c8a4976d37c4ee2f8d"><gtr:id>c4cc85d0fa6cc2c8a4976d37c4ee2f8d</gtr:id><gtr:otherNames>Ali BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12CC5316-7F1A-4748-9071-B2D3B725B320"><gtr:id>12CC5316-7F1A-4748-9071-B2D3B725B320</gtr:id><gtr:title>Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3605cf4918e144e4220e42bf5e20c358"><gtr:id>3605cf4918e144e4220e42bf5e20c358</gtr:id><gtr:otherNames>An B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9C632AC0-116F-4CDC-AFAC-D56B63C53D25"><gtr:id>9C632AC0-116F-4CDC-AFAC-D56B63C53D25</gtr:id><gtr:title>Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.</gtr:title><gtr:parentPublicationTitle>Matrix biology : journal of the International Society for Matrix Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/278fcc443baec484a682f08515697559"><gtr:id>278fcc443baec484a682f08515697559</gtr:id><gtr:otherNames>Xu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0945-053X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4DE41131-573C-4170-91C9-5A1BE90DBBE0"><gtr:id>4DE41131-573C-4170-91C9-5A1BE90DBBE0</gtr:id><gtr:title>Discoidin domain receptors promote a1?1- and a2?1-integrin mediated cell adhesion to collagen by enhancing integrin activation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/278fcc443baec484a682f08515697559"><gtr:id>278fcc443baec484a682f08515697559</gtr:id><gtr:otherNames>Xu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D186EE2-6DA0-489D-816F-117D989AA57E"><gtr:id>3D186EE2-6DA0-489D-816F-117D989AA57E</gtr:id><gtr:title>Crystallographic insight into collagen recognition by discoidin domain receptor 2.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/772f41bd5d1ccd2d477ccb20e7541a6a"><gtr:id>772f41bd5d1ccd2d477ccb20e7541a6a</gtr:id><gtr:otherNames>Carafoli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5F86FF4-2081-48F0-84F5-5EEBC16E0573"><gtr:id>D5F86FF4-2081-48F0-84F5-5EEBC16E0573</gtr:id><gtr:title>Extracellular matrix component signaling in cancer.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3cba274516be7d870dc673cc09ae080"><gtr:id>c3cba274516be7d870dc673cc09ae080</gtr:id><gtr:otherNames>Multhaupt HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8F2A95F-B9DD-44E6-8A28-0525DE1429C6"><gtr:id>B8F2A95F-B9DD-44E6-8A28-0525DE1429C6</gtr:id><gtr:title>Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/772f41bd5d1ccd2d477ccb20e7541a6a"><gtr:id>772f41bd5d1ccd2d477ccb20e7541a6a</gtr:id><gtr:otherNames>Carafoli F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A3D11EC-4C4B-44FD-B8A9-E853FE479DA9"><gtr:id>4A3D11EC-4C4B-44FD-B8A9-E853FE479DA9</gtr:id><gtr:title>Discoidin domain receptor tyrosine kinases: new players in cancer progression.</gtr:title><gtr:parentPublicationTitle>Cancer metastasis reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55da4430ae45a3197b7564b39ecc57db"><gtr:id>55da4430ae45a3197b7564b39ecc57db</gtr:id><gtr:otherNames>Valiathan RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0167-7659</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2F8B45DF-92FB-4299-B8CD-2F29D4249E82"><gtr:id>2F8B45DF-92FB-4299-B8CD-2F29D4249E82</gtr:id><gtr:title>Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb9696ed7d54214ca5185e42d21e803b"><gtr:id>fb9696ed7d54214ca5185e42d21e803b</gtr:id><gtr:otherNames>Valencia K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F57E13B2-DEDE-41FF-BC04-1E4698E03611"><gtr:id>F57E13B2-DEDE-41FF-BC04-1E4698E03611</gtr:id><gtr:title>Discoidin domain receptor functions in physiological and pathological conditions.</gtr:title><gtr:parentPublicationTitle>International review of cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/79e81d2242446d150effd6eadfd52a81"><gtr:id>79e81d2242446d150effd6eadfd52a81</gtr:id><gtr:otherNames>Leitinger B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1937-6448</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/030FB1DB-74B4-411D-B572-799400E0EAEB"><gtr:id>030FB1DB-74B4-411D-B572-799400E0EAEB</gtr:id><gtr:title>Transmembrane collagen receptors.</gtr:title><gtr:parentPublicationTitle>Annual review of cell and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/79e81d2242446d150effd6eadfd52a81"><gtr:id>79e81d2242446d150effd6eadfd52a81</gtr:id><gtr:otherNames>Leitinger B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1081-0706</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701121</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>